Health
Remdesivir Blocks Covid-19 Coronavirus, But Is It Worth The Cost? – Forbes
While WHO doesn’t recommend using remdesivir, recent studies reveal how the drug disrupts the virus.
Remdesivir.
getty
While clinical trials suggest ‘remdesivir’ is not very effective in treating Covid-19, recent studies have shown that it does block Coronavirus activity.
That apparent contradiction makes the antiviral drug even more controversial.
Remdesivir is an experimental drug developed by biotech company Gilead Sciences (under the brand name Veklury) in collaboration with the Centres for Disease Control and Army Medical Research Institute of Infectious Diseases.
It’s one of many drug candidates…
-
General20 hours agoRestaurants on the brink as business failures plateau
-
General9 hours agoThree maps that show the scale of the NSW flood disaster
-
General23 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General20 hours agoRegional house price growth outstrips capital cities